|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,583,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,917,000 |
Avg
Vol: |
889,275 |
52
Week Range: |
$259.55 - $259.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Halvorson Eric H |
Director |
|
2014-03-04 |
4 |
S |
$138.33 |
$480,282 |
D/D |
(3,472) |
1,000 |
|
- |
|
Halvorson Eric H |
Director |
|
2014-03-04 |
4 |
OE |
$14.26 |
$61,332 |
D/D |
3,472 |
4,472 |
|
- |
|
Chang Betty Y |
VP, Research/Biology |
|
2014-03-04 |
4 |
S |
$137.97 |
$2,414,484 |
D/D |
(17,500) |
3,754 |
|
- |
|
Chang Betty Y |
VP, Research/Biology |
|
2014-03-04 |
4 |
OE |
$7.69 |
$179,238 |
D/D |
17,500 |
21,254 |
|
- |
|
Van Den Broek Richard |
Director |
|
2014-02-27 |
4 |
S |
$144.92 |
$3,622,990 |
I/I |
(25,000) |
29,610 |
|
- |
|
Van Den Broek Richard |
Director |
|
2014-02-26 |
4 |
S |
$147.13 |
$3,778,170 |
I/I |
(25,680) |
54,610 |
|
- |
|
Van Den Broek Richard |
Director |
|
2014-02-25 |
4 |
S |
$147.70 |
$4,158,496 |
I/I |
(28,155) |
80,290 |
|
- |
|
Soni Manmeet Singh |
Chief Financial Officer |
|
2014-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
32,406 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2013-12-30 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,290 |
30,312 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2013-12-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,290 |
13,492,378 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2013-12-30 |
4 |
OE |
$0.75 |
$9,750 |
D/D |
13,000 |
38,004 |
|
- |
|
Tan Heow |
Chief Quality&Tech Operations |
|
2013-12-24 |
4 |
OE |
$27.05 |
$40,575 |
D/D |
1,500 |
1,669 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2013-12-24 |
5 |
GA |
$0.00 |
$0 |
I/I |
21,438 |
21,438 |
|
- |
|
Smith David Duane |
Director |
|
2013-12-20 |
4 |
OE |
$1.92 |
$1,920 |
D/D |
1,000 |
3,000 |
|
- |
|
Tan Heow |
Chief Quality&Tech Operations |
|
2013-12-19 |
4 |
S |
$100.78 |
$504,352 |
D/D |
(5,000) |
169 |
|
- |
|
Tan Heow |
Chief Quality&Tech Operations |
|
2013-12-19 |
4 |
OE |
$27.05 |
$135,250 |
D/D |
5,000 |
5,169 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2013-12-18 |
4 |
S |
$99.04 |
$990,380 |
D/D |
(10,000) |
25,004 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2013-12-18 |
4 |
OE |
$0.86 |
$8,600 |
D/D |
10,000 |
35,004 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2013-12-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,000) |
371,119 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2013-12-17 |
4 |
S |
$102.00 |
$1,020,000 |
D/D |
(10,000) |
25,004 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2013-12-17 |
4 |
OE |
$0.86 |
$8,600 |
D/D |
10,000 |
35,004 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2013-12-16 |
4 |
S |
$107.55 |
$2,151,000 |
D/D |
(20,000) |
210,107 |
|
- |
|
Smith David Duane |
Director |
|
2013-12-16 |
4 |
OE |
$106.85 |
$694,544 |
D/D |
6,500 |
2,000 |
|
- |
|
Smith David Duane |
Director |
|
2013-12-16 |
4 |
OE |
$1.92 |
$12,480 |
D/D |
6,500 |
8,500 |
|
- |
|
Erdtmann Rainer M |
Sr. VP, IR and Admin |
|
2013-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
5,497 |
|
- |
|
344 Records found
|
|
Page 2 of 14 |
|
|